Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 383

Similar articles for PubMed (Select 19368956)

1.

Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.

Cheng H, Dodge J, Mehl E, Liu S, Poulin N, van de Rijn M, Nielsen TO.

Hum Pathol. 2009 Sep;40(9):1244-51. doi: 10.1016/j.humpath.2009.01.011. Epub 2009 Apr 14.

PMID:
19368956
2.

p27(kip1) protein expression correlates with survival in myxoid and round-cell liposarcoma.

Oliveira AM, Nascimento AG, Okuno SH, Lloyd RV.

J Clin Oncol. 2000 Aug;18(15):2888-93.

PMID:
10920137
3.

Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.

Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL.

Am J Surg Pathol. 2009 May;33(5):645-58. doi: 10.1097/PAS.0b013e3181963c9c.

PMID:
19194281
4.

[Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].

Lanckohr C, Kasprzynski A, Klein-Hitpass L, Homann HH, Lehnhardt M, Müller O, Kuhnen C, Herter P.

Pathologe. 2010 Feb;31(1):60-6. doi: 10.1007/s00292-009-1234-0. Review. German. Erratum in: Pathologe. 2010 May;31(3):198.

PMID:
19823827
5.
6.

Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.

Heerema-McKenney A, Wijnaendts LC, Pulliam JF, Lopez-Terrada D, McKenney JK, Zhu S, Montgomery K, Mitchell J, Marinelli RJ, Hart AA, van de Rijn M, Linn SC.

Am J Surg Pathol. 2008 Oct;32(10):1513-22. doi: 10.1097/PAS.0b013e31817a909a.

PMID:
18708938
7.

Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.

Oda Y, Yamamoto H, Takahira T, Kobayashi C, Kawaguchi K, Tateishi N, Nozuka Y, Tamiya S, Tanaka K, Matsuda S, Yokoyama R, Iwamoto Y, Tsuneyoshi M.

J Pathol. 2005 Dec;207(4):410-21.

PMID:
16177957
9.

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.

Francis P, Namløs HM, Müller C, Edén P, Fernebro J, Berner JM, Bjerkehagen B, Akerman M, Bendahl PO, Isinger A, Rydholm A, Myklebost O, Nilbert M.

BMC Genomics. 2007 Mar 14;8:73.

10.

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG, Gronchi A.

Cancer. 2007 Jun 15;109(12):2522-31.

11.

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M.

Clin Cancer Res. 2001 Dec;7(12):3977-87.

12.

Novel role for RGS1 in melanoma progression.

Rangel J, Nosrati M, Leong SP, Haqq C, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

Am J Surg Pathol. 2008 Aug;32(8):1207-12. doi: 10.1097/PAS.0b013e31816fd53c.

PMID:
18580492
13.

A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.

Würl P, Lautenschläger C, Meye A, Schmidt H, Bache M, Rath FW, Schönfelder M, Taubert H.

Anticancer Res. 2000 May-Jun;20(3B):2065-72.

PMID:
10928153
14.

Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.

Meis-Kindblom JM, Sjögren H, Kindblom LG, Peydró-Mellquist A, Röijer E, Aman P, Stenman G.

Virchows Arch. 2001 Aug;439(2):141-51.

PMID:
11561754
15.

Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.

ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E, Suurmeijer AJ.

Ann Surg Oncol. 2007 Jan;14(1):222-9. Epub 2006 Oct 22.

PMID:
17058128
16.

Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.

Nishida Y, Tsukushi S, Nakashima H, Ishiguro N.

Clin Orthop Relat Res. 2010 Nov;468(11):3041-6. doi: 10.1007/s11999-010-1396-3.

17.
18.

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia.

Orvieto E, Furlanetto A, Laurino L, Dei Tos AP.

Semin Diagn Pathol. 2001 Nov;18(4):267-73. Review.

PMID:
11757867
19.

Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma.

Demicco EG, Torres KE, Ghadimi MP, Colombo C, Bolshakov S, Hoffman A, Peng T, Bovée JV, Wang WL, Lev D, Lazar AJ.

Mod Pathol. 2012 Feb;25(2):212-21. doi: 10.1038/modpathol.2011.148. Epub 2011 Oct 21.

20.

Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.

Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B.

Hum Pathol. 2009 Apr;40(4):527-37. doi: 10.1016/j.humpath.2008.10.003. Epub 2009 Jan 3.

PMID:
19121847
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk